Search Results

There are 6234 results for: content related to: Effectiveness and safety of varenicline as an aid to smoking cessation: results of an inter-Asian observational study in real-world clinical practice

  1. Nicotine receptor partial agonists for smoking cessation

    Intervention Review

    The Cochrane Library

    Kate Cahill, Nicola Lindson-Hawley, Kyla H Thomas, Thomas R Fanshawe and Tim Lancaster

    Published Online : 9 MAY 2016, DOI: 10.1002/14651858.CD006103.pub7

  2. You have free access to this content
    Pharmacological interventions for smoking cessation: an overview and network meta-analysis

    Overview of Reviews

    The Cochrane Library

    Kate Cahill, Sarah Stevens, Rafael Perera and Tim Lancaster

    Published Online : 31 MAY 2013, DOI: 10.1002/14651858.CD009329.pub2

  3. The effect of varenicline on the development and expression of nicotine-induced behavioral sensitization and cross-sensitization in rats

    Addiction Biology

    Volume 20, Issue 2, March 2015, Pages: 248–258, Wouter Goutier, Margreet B. Kloeze and Andrew C. McCreary

    Version of Record online : 20 NOV 2013, DOI: 10.1111/adb.12108

  4. Effects of Varenicline on Ethanol-Induced Conditioned Place Preference, Locomotor Stimulation, and Sensitization

    Alcoholism: Clinical and Experimental Research

    Volume 38, Issue 12, December 2014, Pages: 3033–3042, Noah R. Gubner, Carrie S. McKinnon and Tamara J. Phillips

    Version of Record online : 7 JAN 2015, DOI: 10.1111/acer.12588

  5. Varenicline efficacy and safety among methadone maintained smokers: a randomized placebo-controlled trial

    Addiction

    Volume 109, Issue 9, September 2014, Pages: 1554–1563, Shadi Nahvi, Yuming Ning, Kate S. Segal, Kimber P. Richter and Julia H. Arnsten

    Version of Record online : 27 JUN 2014, DOI: 10.1111/add.12631

  6. You have free access to this content
    Interventions for smoking cessation and reduction in individuals with schizophrenia

    Intervention Review

    The Cochrane Library

    Daniel T Tsoi, Mamta Porwal and Angela C Webster

    Published Online : 28 FEB 2013, DOI: 10.1002/14651858.CD007253.pub3

  7. Multiple-Dose Pharmacokinetics of the Selective Nicotinic Receptor Partial Agonist, Varenicline, in Healthy Smokers

    The Journal of Clinical Pharmacology

    Volume 46, Issue 12, December 2006, Pages: 1439–1448, Dr Hélène M. Faessel, Dr Megan A. Gibbs, Dr David J. Clark, Mr Kevin Rohrbacher, Dr Marilyn Stolar and Dr Aaron H. Burstein

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270006292624

  8. You have full text access to this OnlineOpen article
    Varenicline decreases ethanol intake and increases dopamine release via neuronal nicotinic acetylcholine receptors in the nucleus accumbens

    British Journal of Pharmacology

    Volume 171, Issue 14, July 2014, Pages: 3420–3431, A A Feduccia, J A Simms, D Mill, H Y Yi and S E Bartlett

    Version of Record online : 25 JUN 2014, DOI: 10.1111/bph.12690

  9. The long-term cost-effectiveness of varenicline (12-week standard course and 12 + 12-week extended course) vs. other smoking cessation strategies in Canada

    International Journal of Clinical Practice

    Volume 68, Issue 5, May 2014, Pages: 639–646, M. von Wartburg, V. Raymond and P. E. Paradis

    Version of Record online : 29 JAN 2014, DOI: 10.1111/ijcp.12363

  10. Pharmacokinetics, Safety, and Tolerability After Single and Multiple Oral Doses of Varenicline in Elderly Smokers

    The Journal of Clinical Pharmacology

    Volume 46, Issue 11, November 2006, Pages: 1234–1240, Dr Aaron H. Burstein, Dr Terence Fullerton, Dr David J. Clark and Dr Hélène M. Faessel

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270006291837

  11. Single-Dose Pharmacokinetics of Varenicline, a Selective Nicotinic Receptor Partial Agonist, in Healthy Smokers and Nonsmokers

    The Journal of Clinical Pharmacology

    Volume 46, Issue 9, September 2006, Pages: 991–998, Dr Hélène M. Faessel, Dr Bill J. Smith, Dr Megan A. Gibbs, Dr Jason S. Gobey, Dr David J. Clark and Dr Aaron H. Burstein

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270006290669

  12. A review of cost-effectiveness of varenicline and comparison of cost-effectiveness of treatments for major smoking-related morbidities

    Journal of Evaluation in Clinical Practice

    Volume 17, Issue 2, April 2011, Pages: 288–297, Evelina A. Zimovetz, Koo Wilson, Miny Samuel and Stephen M. Beard

    Version of Record online : 4 OCT 2010, DOI: 10.1111/j.1365-2753.2010.01439.x

  13. Cross-Validation of a New Procedure for Early Screening of Smoking Cessation Medications in Humans

    Clinical Pharmacology & Therapeutics

    Volume 88, Issue 1, July 2010, Pages: 109–114, K A Perkins, C Lerman, C A Fonte, M Mercincavage, M L Stitzer, K N R Chengappa and A Jain

    Version of Record online : 19 MAY 2010, DOI: 10.1038/clpt.2010.65

  14. Lack of Pharmacokinetic and Pharmacodynamic Interactions Between a Smoking Cessation Therapy, Varenicline, and Warfarin: An In Vivo and In Vitro Study

    The Journal of Clinical Pharmacology

    Volume 47, Issue 11, November 2007, Pages: 1421–1429, Dr Aaron H. Burstein, Dr David J. Clark, Ms Melissa O'Gorman, Dr Susan A. Willavize, Mr Timothy G. Brayman, Mr G. Scott Grover, Mr Robert L. Walsky, Dr R. Scott Obach and Dr Hélène M. Faessel

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270007307574

  15. You have free access to this content
    The Effects of Extended Pre-Quit Varenicline Treatment on Smoking Behavior and Short-Term Abstinence: A Randomized Clinical Trial

    Clinical Pharmacology & Therapeutics

    Volume 91, Issue 2, February 2012, Pages: 172–180, L W Hawk Jr, R L Ashare, S F Lohnes, N J Schlienz, J D Rhodes, S T Tiffany, J C Gass, K M Cummings and M C Mahoney

    Version of Record online : 30 NOV 2011, DOI: 10.1038/clpt.2011.317

  16. Abstinence and relapse among smokers who use varenicline in a quit attempt—a pooled analysis of randomized controlled trials

    Addiction

    Volume 110, Issue 7, July 2015, Pages: 1182–1193, Shade A. Agboola, Tim Coleman, Ann McNeill and Jo Leonardi-Bee

    Version of Record online : 12 JUN 2015, DOI: 10.1111/add.12941

  17. You have full text access to this OnlineOpen article
    Varenicline and Nicotine Patch Therapies in Young Adults Motivated to Quit Smoking: A Randomized, Placebo-controlled, Prospective Study

    Basic & Clinical Pharmacology & Toxicology

    Anna Tuisku, Merita Salmela, Pentti Nieminen and Tuula Toljamo

    Version of Record online : 25 JAN 2016, DOI: 10.1111/bcpt.12548

  18. Fifty-two-week continuous abstinence rates of smokers being treated with varenicline versus nicotine replacement therapy

    Addiction

    Volume 108, Issue 8, August 2013, Pages: 1497–1502, Eva Kralikova, Alexandra Kmetova, Lenka Stepankova, Kamila Zvolska, Rachel Davis and Robert West

    Version of Record online : 13 MAY 2013, DOI: 10.1111/add.12219

  19. Pharmacokinetics, Safety, and Tolerability Following Multiple Oral Doses of Varenicline Under Various Titration Schedules in Elderly Nonsmokers

    The Journal of Clinical Pharmacology

    Volume 51, Issue 4, April 2011, Pages: 492–501, Dr Qinying Zhao, Dr Elias Schwam, Dr Terence Fullerton, Ms Melissa O'Gorman and Dr Aaron H. Burstein

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010370461

  20. You have free access to this content
    AT-1001: a high-affinity α3β4 nAChR ligand with novel nicotine-suppressive pharmacology

    British Journal of Pharmacology

    Volume 172, Issue 7, April 2015, Pages: 1834–1845, Andrea Cippitelli, Jinhua Wu, Kelly A Gaiolini, Daniela Mercatelli, Jennifer Schoch, Michelle Gorman, Alejandra Ramirez, Roberto Ciccocioppo, Taline V Khroyan, Dennis Yasuda, Nurulain T Zaveri, Conrado Pascual, Xinmin (Simon) Xie and Lawrence Toll

    Version of Record online : 23 JAN 2015, DOI: 10.1111/bph.13034